Author:

Keywords:

Science & Technology, Life Sciences & Biomedicine, Clinical Neurology, Neurosciences & Neurology, PROGRESSIVE MUSCULAR-ATROPHY, FRONTOTEMPORAL LOBAR DEGENERATION, FLAIL ARM SYNDROME, HEXANUCLEOTIDE REPEAT, NATURAL-HISTORY, COGNITIVE IMPAIRMENT, SUPEROXIDE-DISMUTASE, MOTONEURON DISEASE, CLINICAL-FEATURES, ALS, Amyotrophic Lateral Sclerosis, Disease Progression, Frontotemporal Dementia, Frontotemporal Lobar Degeneration, Humans, Phenotype, 3202 Clinical sciences, 3209 Neurosciences

Abstract:

Classic textbook neurology teaches that amyotrophic lateral sclerosis (ALS) is a degenerative disease that selectively affects upper and lower motor neurons and is fatal 3-5 years after onset-a description which suggests that the clinical presentation of ALS is very homogenous. However, clinical and postmortem observations, as well as genetic studies, demonstrate that there is considerable variability in the phenotypic expression of ALS. Here, we review the phenotypic variability of ALS and how it is reflected in familial and sporadic ALS, in the degree of upper and lower motor neuron involvement, in motor and extramotor involvement, and in the spectrum of ALS and frontotemporal dementia. Furthermore, we discuss some unusual clinical characteristics regarding presentation, age at onset and disease progression. Finally, we address the importance of this variability for understanding the pathogenesis of ALS and for the development of therapeutic strategies.